Santarelli, R.; Pompili, C.; Gilardini Montani, M.S.; Evangelista, L.; Gonnella, R.; Cirone, M.
3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells. Pharmaceutics 2022, 14, 663.
https://doi.org/10.3390/pharmaceutics14030663
AMA Style
Santarelli R, Pompili C, Gilardini Montani MS, Evangelista L, Gonnella R, Cirone M.
3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells. Pharmaceutics. 2022; 14(3):663.
https://doi.org/10.3390/pharmaceutics14030663
Chicago/Turabian Style
Santarelli, Roberta, Chiara Pompili, Maria Saveria Gilardini Montani, Lorenzo Evangelista, Roberta Gonnella, and Mara Cirone.
2022. "3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells" Pharmaceutics 14, no. 3: 663.
https://doi.org/10.3390/pharmaceutics14030663
APA Style
Santarelli, R., Pompili, C., Gilardini Montani, M. S., Evangelista, L., Gonnella, R., & Cirone, M.
(2022). 3,4-Dihydroxyphenylethanol (DPE or Hydroxytyrosol) Counteracts ERK1/2 and mTOR Activation, Pro-Inflammatory Cytokine Release, Autophagy and Mitophagy Reduction Mediated by Benzo[a]pyrene in Primary Human Colonic Epithelial Cells. Pharmaceutics, 14(3), 663.
https://doi.org/10.3390/pharmaceutics14030663
